IMBiologics Inc. announced that it has received KRW 20,000 million in a round of funding on July 24, 2023. The transaction included participation from returning investors, KB Investment & Securities Co., Ltd., Investment Arm, Atinum Investment Co., Ltd, Partners Investment Co., Ltd., CJ Investment Inc., new investors, K2 Investment Partners LLC, Shinhan Venture Investment Co, Ltd., Yuanta Securities Korea Co., Ltd., Investment Arm, Prodigy Investment, Solidus Investment Co., Ltd., Wooshin Venture Investment Corp., Shinhan Capital Co., Ltd., Kingo Investment Partners Co. Ltd., Woori Financial Group Inc., Ard Partners Limited, LSK Investment and NS Investment Co., Ltd. The company has raised KRW 37,000 million in funding till date.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,050 KRW | +3.57% | +5.17% | -14.92% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
14,870 KRW | +0.88% | +1.92% | 804.7Cr | ||
3,050 KRW | +3.57% | +5.17% | 10Cr | ||
1st Jan change | Capi. | |
---|---|---|
-14.92% | 10Cr | |
+17.13% | 311.04Cr | |
+12.82% | 176.95Cr | |
+8.43% | 151.82Cr | |
-11.54% | 120.46Cr | |
+15.63% | 80Cr | |
+9.62% | 67Cr | |
+32.49% | 57Cr | |
-4.17% | 50Cr | |
+46.43% | 48Cr |
- Stock Market
- Equities
- A021080 Stock
- News Atinum Investment Co., Ltd
- IMBiologics Inc. announced that it has received KRW 20 billion in funding from a group of investors